DI MAIO M.

No description

Background: During COVID-19 outbreak, oncological care has been reorganized. Cancer patients have been reported to experience a more severe COVID-19 syndrome; moreover, there are concerns of an interference between immune checkpoint inhibitors (ICIs) and SARS-CoV-2 pathogenesis. Materials and Methods: Between May 6 and 16, 2020, a 22-item...

The characteristics and clinical course of hospitalized patients with coronavirus disease 2019 (COVID-19) have been widely described, while long-term data are still poor. The aim of this study was to evaluate the long-term clinical outcome and its association with right ventricular (RV) dysfunction in hospitalized patients with COVID-19. This...

High mortality rates in elderly patients or in those with underlying chronic illnesses and/or a compromised immune system is a peculiar feature of COVID-19 infection. The possible coexistence of a cancer and COVID-19 infection in the same individual prompted concerns regarding their synergistic effect on prognosis. In order to balance patients'...

Introduction: Advanced stage malignant mesothelioma (asMM) patients have poor prognosis. Several trials investigated the role of programmed cell death protein-1 (PD-1) and its ligand 1 (PD-L1) immune checkpoint inhibitors (ICIs) in pre-treated asMM. Methods: A systematic review of the literature of clinical trials testing single-agent anti...